Chia-Cheng Yu

National Yang Ming Chiao Tung University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Chia-Cheng Yu is a leading urologic oncologist whose research focuses on upper tract urothelial carcinoma (UTUC), a malignancy with uniquely high prevalence in Taiwan. His major contributions center on optimizing surgical outcomes for UTUC, particularly through comparative effectiveness studies of minimally invasive versus open radical nephroureterectomy. His landmark 2025 paper, which has already garnered 2 citations, provides critical real-world evidence from Taiwan demonstrating that minimally invasive approaches can achieve comparable survival outcomes to open surgery while offering potential recovery benefits. This work is especially significant given that UTUC accounts for 30-40% of urothelial cancers in Taiwan—a rate far exceeding global averages—making region-specific data essential for clinical decision-making. Dr. Yu’s research directly addresses the surgical management challenges of this population, helping to establish evidence-based guidelines for radical nephroureterectomy with bladder cuff excision. His findings have important implications for reducing surgical morbidity without compromising oncologic control, positioning him as a key voice in the ongoing debate over surgical approaches for this aggressive disease.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Comparative survival outcomes of minimally invasive versus open radical nephroureterectomy for upper tract urothelial carcinoma in Taiwan
2 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: National Yang Ming Chiao Tung University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago